RNA Formulation Resources
-
Mechanisms Of LNP-Mediated mRNA Delivery
Explore the details supporting LNP-mediated mRNA delivery, as well as the challenges facing mRNA based therapeutics in the future.
-
Reducing Risk In mRNA Therapeutic Development
8/12/2024
Advancements in purification, delivery mechanisms, and stability during storage and transport will enable the future of mRNA-based therapies.
-
Lipid Nanoparticle Compositional Analysis By UHPLC-CAD
6/30/2023
Explore results generated from an internal study using a proprietary mRNA-LNP formulation and UHPLC-CAD, a powerful technique for the analysis of compounds that do not contain chromophores.
-
Translation Of RNA Medicines From Design To Clinic
3/2/2022
Understand the advantages and challenges of lipid-based delivery systems for successful translation of RNA into clinical development.
-
Process Development Considerations For RNA-LNP Therapeutics
9/13/2022
Here, we highlight three important process considerations across the RNA-LNP manufacturing workflow which includes limit size behavior, in-line dilution and downstream tangential flow filtration (TFF).
-
The Heroes Of Vaccine Development: Lipid Nanoparticles
2/8/2024
Lipid nanoparticles (LNPs) have played a crucial role in COVID-19 vaccine development as efficient mRNA delivery systems, exhibiting versatility and effectiveness in accelerating the process.
-
Fit-For-Purpose Lipids Can Accelerate, Scale, And Improve RNA-LNP Drugs
6/22/2023
Emerging biotech companies are investing in novel delivery capabilities to address different modalities' needs and extra-hepatic delivery. Explore steps to accelerate commercial nanomedicine delivery.
-
Development And Optimization Of LNP Formulations
12/6/2024
The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs.
-
mRNA Manufacturing And Formulation
11/15/2022
From fermentation to formulation, mRNA manufacturing requires a toolbox of technologies, services, and expertise. Explore our portfolio of solutions for making, purifying, and formulating mRNA.
-
Scale-Up And Manufacturing Of Self-Amplifying RNA-LNPs
4/18/2022
This poster shows the work to scale up COVID-19 self-amplifying RNA-Lipid nanoparticle using PNI developed ionizable lipid and formulation from 0.2, to 50 mg scale using PNI’s Manufacturing Platform.